About

Publications While At HealthPartners

selected publications

Journal Article

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 

British Journal of Cancer. 2023

Phase I study of IGF-methotrexate conjugate in the treatment of advanced tumors expressing IGF-1R. 

American Journal of Clinical Oncology. 2019

Phase I study of aurora A kinase inhibitor alisertib (MLN8237) in combination with selective VEGFR inhibitor pazopanib for therapy of advanced solid tumors. 

American Journal of Clinical Oncology. 2019

Contact

full name

O. C. Danciu

Quick Info

 

Collaboration

Co-author network

Map of science